Friday, November 22, 2024
HomeTagsBiopharmaceuticals

Biopharmaceuticals

Inmagene Receives FDA’s IND Clearance for OX40 Antagonist

Inmagene Biopharmaceuticals ("Inmagene") announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed...

Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial

The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz) Also...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics